Nevertheless, existing data correlating 25-hydroxyvitamin D [25(OH)D] concentrations with clinical outcomes post anti-VEGF therapy in diabetic macular edema continues to be limited and inconclusive. The gene discussed is VEGFA; the disease is diabetic macular edema.